Lv0
0 积分 2025-09-03 加入
A CDER perspective: Landscape of New Approach Methodologies (NAMs) submitted in drug development programs
1天前
待确认
Rethinking the necessity of long-term toxicity studies for biotherapeutics using weight of evidence assessment
1天前
已完结
Implementation of the principles of the 3Rs of animal testing at CDER: Past, present and future
1天前
已完结
Strategies to reduce the use of non-human primates in development of oncology ADCs with cytotoxic payloads
4天前
已完结
Strategies to reduce the use of non-human primates in development of oncology ADCs with cytotoxic payloads
4天前
已完结
The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution
4天前
已完结
Targeting nitroreductases for selective drug activation: therapeutic perspectives in neglected diseases and tuberculosis
5天前
已完结
Prasugrel: A Novel Thienopyridine Antiplatelet Agent. A Review of Preclinical and Clinical Studies and the Mechanistic Basis for Its Distinct Antiplatelet Profile
6天前
已完结
Ultrasensitive Near-Infrared Fluorescence-Enhanced Probe for in Vivo Nitroreductase Imaging
9天前
已完结
Macrophage phagocytosis assay with reconstituted target particles
11天前
已完结
皖公网安备34019202002308
